机构:[1]China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China;[2]Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou 325035, Zhejiang, Peoples R China;[3]China Acad Chinese Med Sci, Grad Sch, Beijing 100700, Peoples R China;[4]Guangdong Med Coll, Dept Pharm, Dong Guan 523808, Peoples R China;[5]Capital Med Univ, Bejing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China;重点科室诊疗科室神经病学中心神经病学中心首都医科大学附属天坛医院[6]Xian Univ, Key Lab Surface Engn & Remfg Shaanxi Prov, Sch Chem Engn, Xian 710065, Peoples R China
Rising worldwide cancer incidence and resistance to current anti-cancer drugs necessitate the need for new pharmaceutical compounds and drug delivery system. Two novel series of biscoumarin (1-4) and dihydropyran (5-16) derivatives were synthesized via a one-pot multicomponent condensation reaction and evaluated for their antitumor activity in vitro. The X-ray crystal structure analysis of four representative compounds 2, 7, 10 and 13 confirmed the structures of these compounds. Compounds 1-4 showed the most potent antitumor activity among the total 16 derivatives. More interestingly, preliminary mechanism studies revealed that the most potent compound 4 induced apoptosis and arrested the cell cycle at the S phase in HUTU80 cells. Additionally, the increased accumulation of HUTU80 cells in the sub G1 peak further pointed to the occurence of the cell apoptosis. The selectivity index analysis demonstrated that all the biscoumarin compounds (SI = 3.1-7.5) possess higher selectivity towards intestinal epithelial adenocarcinoma cell line (HuTu80) than positive control drug carboplatin (SI = 1.6-1.8). The biscoumarin compounds also showed no obvious acute toxicity on mice. (C) 2016 Elsevier Ltd. All rights reserved.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81274112, 81373986, 81473372, 81403125, 81403322]; Beijing Municipal Natural Science FoundationBeijing Natural Science Foundation [7152106]; Science and Technology Project Foundation Xi'an [CXY1352WL06]
第一作者机构:[1]China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China;
通讯作者:
通讯机构:[1]China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China;[6]Xian Univ, Key Lab Surface Engn & Remfg Shaanxi Prov, Sch Chem Engn, Xian 710065, Peoples R China
推荐引用方式(GB/T 7714):
Zhou Hai-Yu,Dong Feng-Quan,Du Xin-Liang,et al.Antitumor activities of biscoumarin and dihydropyran derivatives[J].BIOORGANIC & MEDICINAL CHEMISTRY LETTERS.2016,26(16):3876-3880.doi:10.1016/j.bmcl.2016.07.023.
APA:
Zhou, Hai-Yu,Dong, Feng-Quan,Du, Xin-Liang,Zhou, Zhi-Kun,Huo, Hai-Ru...&Zhai, Yun-Hui.(2016).Antitumor activities of biscoumarin and dihydropyran derivatives.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,26,(16)
MLA:
Zhou, Hai-Yu,et al."Antitumor activities of biscoumarin and dihydropyran derivatives".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 26..16(2016):3876-3880